Remedy Robotics is a medical technology company building the world's first remotely operable endovascular robotic platform, the Remedy N1 system. It aims to revolutionize cardiovascular care by enabling specialists to perform flawless, immediate endovascular interventions for conditions like stroke, heart attack, bleeding, and aneurysms, regardless of the patient's location.
- Category
- Robotics
- Stage
- Series A
- Employees
- 18
- HQ
- San Francisco, United States
- Founded
- 2020
- Funding
- $35M